ArticleTranslational lung cancer research2026
DNA hypomethylation-activated PRAME drives early-stage lung adenocarcinoma recurrence via ZNF740 and PI3K/AKT/mTOR signaling.
Guo-Nian Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.